ISRG (Intuitive Surgical Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ISRG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-08-19 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-08-12 | GARY S GUTHART | Director | Sell | — | — |
| 2026-08-11 | Amy L Ladd | Director | Sell | — | — |
| 2026-08-10 | GARY LOEB | EVP & Chief Legal and Complian | Sell | — | — |
| 2026-07-31 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-07-29 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-07-13 | David J. Rosa | Chief Executive Officer (CEO) | MIXED | — | — |
| 2026-06-12 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-06-10 | GARY LOEB | EVP & Chief Legal and Complian | Sell | — | — |
| 2026-06-10 | David J. Rosa | Chief Executive Officer (CEO) | MIXED | — | — |
| 2026-06-10 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-06-02 | Iman Jeddi | SVP & GM da Vinci Platforms & | MIXED | — | — |
| 2026-05-22 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-05-20 | Mark Brosius | EVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-05-11 | GARY LOEB | EVP & Chief Legal and Complian | Sell | — | — |
| 2026-05-01 | GARY S GUTHART | Director | A | — | — |
| 2026-04-30 | CRAIG H BARRATT | Director | M | — | — |
| 2026-04-30 | Joseph C Beery | Director | M | — | — |
| 2026-04-30 | LEWIS CHEW | Director | M | — | — |
| 2026-04-30 | Amal M Johnson | Director | M | — | — |
| 2026-04-30 | Sreelakshmi Kolli | Director | M | — | — |
| 2026-04-30 | Amy L Ladd | Director | M | — | — |
| 2026-04-30 | Keith R Leonard | Director | M | — | — |
| 2026-04-30 | JAMI K NACHTSHEIM | Director | M | — | — |
| 2026-04-30 | Monica P Reed | Director | M | — | — |
| 2026-04-29 | Amy L Ladd | Director | Sell | — | — |
| 2026-03-11 | Myriam Curet | EVP & Chief Medical Officer | MIXED | — | — |
| 2026-03-10 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-03-05 | Mark Brosius | SVP & Chief Mfg and Supply Cha | Sell | — | — |
| 2026-03-03 | GARY S GUTHART | Director | MIXED | — | — |
| 2026-03-03 | Iman Jeddi | SVP & GM da Vinci Platforms & | MIXED | — | — |
| 2026-03-03 | Myriam Curet | EVP & Chief Medical Officer | MIXED | — | — |
| 2026-03-03 | Fredrik Widman | VP Corporate Controller | MIXED | — | — |
| 2026-03-02 | Myriam Curet | EVP & Chief Medical Officer | MIXED | — | — |
| 2026-03-02 | Mark Brosius | SVP & Chief Mfg and Supply Cha | MIXED | — | — |
| 2026-03-02 | David J. Rosa | Chief Executive Officer (CEO) | MIXED | — | — |
| 2026-03-02 | Henry L Charlton | EVP & Chief Commercial and Mkt | MIXED | — | — |
| 2026-03-02 | GARY LOEB | EVP & Chief Legal and Complian | MIXED | — | — |
| 2026-03-02 | Jamie Samath | EVP & CFO & Enterprise Technol | MIXED | — | — |
| 2026-02-27 | Mark Brosius | SVP & Chief Mfg and Supply Cha | MIXED | — | — |
| 2026-02-27 | GARY S GUTHART | Director | MIXED | — | — |
| 2026-02-27 | David J. Rosa | Chief Executive Officer (CEO) | MIXED | — | — |
| 2026-02-27 | Fredrik Widman | VP Corporate Controller | MIXED | — | — |
| 2026-02-27 | Myriam Curet | EVP & Chief Medical Officer | MIXED | — | — |
| 2026-02-27 | GARY LOEB | EVP & Chief Legal and Complian | MIXED | — | — |
| 2026-02-27 | Jamie Samath | EVP & CFO & Enterprise Technol | MIXED | — | — |
| 2026-02-27 | Henry L Charlton | EVP & Chief Commercial and Mkt | MIXED | — | — |
| 2026-02-27 | Iman Jeddi | SVP & GM da Vinci Platforms & | MIXED | — | — |
| 2026-02-27 | PATRICIA L WADORS | SVP Chief Human Resources Offi | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 1,726,776 | — |
| — | Director | 1,256,193 | — |
| — | Chief Executive Officer (CEO) | 247,803 | — |
| — | Executive VP Global Business S | 151,505 | — |
| — | Sr Advisor - Commercial Ops | 73,917 | — |
| — | Director | 44,811 | — |
| — | SVP & GM da Vinci Platforms & | 38,737 | — |
| — | Director | 36,450 | — |
| — | SVP General Counsel & CCO | 30,156 | — |
| — | Director | 29,061 | — |
| — | Director | 28,698 | — |
| — | Director | 25,888 | — |
| — | Director | 24,813 | — |
| — | EVP & CFO & Enterprise Technol | 20,709 | — |
| — | Sr VP General Counsel & CCO | 17,499 | — |
| — | Director | 16,790 | — |
| — | EVP & Chief Operating Officer | 16,113 | — |
| — | Director | 14,253 | — |
| — | Director | 13,545 | — |
| — | Director | 10,269 | — |
| — | GM & SVP Secondary Mkt Equip & | 10,116 | — |
| — | EVP & Chief Digital Officer | 7,960 | — |
| — | Director | 6,902 | — |
| — | EVP & Chief Commercial and Mkt | 5,972 | — |
| — | EVP & Chief Legal and Complian | 5,320 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ISRG quote page; the site-wide leaderboard is on the insider transactions hub.